💊 Drugs • 11,927 recalls
Upsher Smith Laboratories
Failed impurities/ degradation specifications: Product is Out of Specification for an unspecified degradation product.
Defective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.
Promise Pharmacy
Presence of precipitate
Upsher Smith Laboratories
Failed impurities/ degradation specifications: Product is Out of Specification for an unspecified degradation product.
Defective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.
CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.
Product Quest Manufacturing
CGMP Deviations: products manufactured under conditions that could impact its product quality.
Labeling: Not Elsewhere Classified-Incorrect NDC and product name identified on blister packs.
Failed dissolution specifications: Out-of-Specification dissolution results obtained during stability testing.
CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.
CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.
Teva Pharmaceuticals USA
Failed Stability Specifications: Out-of-specification test result for water content obtained during routine stability testing.
CGMP deviations
Takeda Development Center Americas
Defective Delivery System: tablets may be missing, in whole or in part, the laser drilled holes on the metformin core of the Actoplus met XR tablets.
Subpotent Drug: One lot of product does not meet the product specification for Assay test at 3 month long term stability condition.
Jubilant Cadista Pharmaceuticals
Discoloration: Presence of dark discoloration or brown spots on the edges of the tablets.
CGMP Deviations; rejected product was used to manufacture final bulk lot
CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.
CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.
Correct Labeled Product Mispack: confirmed report involving a single unit of properly labeled Heparin in 0.45% Sodium Chloride for Injection (NDC 0409-7651-03, Lot 87903FW) that was found inside a case of Magnesium Sulfate in Water for Injection.